Natural killer cells and tumor control

Sarah A Cooley, Daniel J Weisdorf

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

Purpose of Review: After hematopoietic cell transplantation (HCT) donor-derived natural killer (NK) cells kill tumor cells to prevent relapse and mediate other beneficial clinical effects including control of infections without inducing graft-vs.-host disease (GVHD). Understanding the determinants of NK cell alloreactivity and function will support improvements in the design of HCT and adoptive cellular therapies. Recent Findings: Refinements to the model of NK cell education or licensing have been made which will inform strategies to develop functional alloreactive NK cells for therapeutic use. Differences in NK cell function have been shown to be dependent on the nature of the stimuli. Recent advances have been made in our understanding of the role of activating NK receptors on education and outcome after HCT. The use of adoptively transferred NK cells to treat hematopoietic malignancies has been expanding. New approaches to modulate target sensitivity to NK cell-mediated killing are under development. Summary: NK cells play an important role in the therapeutic efficacy of HCT, with effects on control of infections, GVHD, engraftment and relapse prevention. Recent advances in our understanding of NK cell biology will support improvements in our ability to exploit NK cells to treat cancer.

Original languageEnglish (US)
Pages (from-to)514-521
Number of pages8
JournalCurrent opinion in hematology
Volume17
Issue number6
DOIs
StatePublished - Nov 1 2010

    Fingerprint

Keywords

  • adoptive immunotherapy
  • hematopoietic cell transplantation
  • killer immunoglobulin-like receptors
  • natural killer cells

Cite this